Prime Medicine, Inc. - Common Stock, $0.00001 par value (PRME)

136 filings reported holding PRME - Prime Medicine, Inc. - Common Stock, $0.00001 par value as of Q3 2024.
Prime Medicine, Inc. - Common Stock, $0.00001 par value (PRME) has 113 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 68.7M shares of 179M outstanding shares and own 38.45% of the company stock.
Largest 10 shareholders include Alphabet Inc. (15.1M shares), ARK Investment Management LLC (5.66M shares), BlackRock, Inc. (5.27M shares), VANGUARD GROUP INC (4.89M shares), T. Rowe Price Investment Management, Inc. (3.81M shares), FMR LLC (3.74M shares), Sumitomo Mitsui Trust Group, Inc. (3.19M shares), Nikko Asset Management Americas, Inc. (3.18M shares), MILLENNIUM MANAGEMENT LLC (2.2M shares), and Redmile Group, LLC (2.07M shares).
This table shows the top 113 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.